Gallbladder cancer is the latest form of cancer to be on the rise among people under 50, similar to bowel, breast, and lung ...
China NMPA accepts Akeso's sNDA penpulimab combination therapy for first-line treatment of hepatocellular carcinoma: Hong Kong Monday, November 25, 2024, 13:00 Hrs [IST] Akeso, In ...